These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38523373)

  • 1. CDKN2 expression is a potential biomarker for T cell exhaustion in hepatocellular carcinoma.
    Wei S; Zhang Y; Kang BE; Park W; Guo H; Nam S; Kang JS; Jeong JH; Jo Y; Ryu D; Jiang Y; Ha KT
    BMB Rep; 2024 Jun; 57(6):287-292. PubMed ID: 38523373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma.
    Barsch M; Salié H; Schlaak AE; Zhang Z; Hess M; Mayer LS; Tauber C; Otto-Mora P; Ohtani T; Nilsson T; Wischer L; Winkler F; Manne S; Rech A; Schmitt-Graeff A; Bronsert P; Hofmann M; Neumann-Haefelin C; Boettler T; Fichtner-Feigl S; van Boemmel F; Berg T; Rimassa L; Di Tommaso L; Saeed A; D'Alessio A; Pinato DJ; Bettinger D; Binder H; John Wherry E; Schultheiss M; Thimme R; Bengsch B
    J Hepatol; 2022 Aug; 77(2):397-409. PubMed ID: 35367533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
    Luo JP; Wang J; Huang JH
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34405225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment.
    Ma LN; Ma Y; Luo X; Ma ZM; Ma LN; Ding XC
    Sci Rep; 2024 May; 14(1):12149. PubMed ID: 38802416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma.
    Hung MH; Lee JS; Ma C; Diggs LP; Heinrich S; Chang CW; Ma L; Forgues M; Budhu A; Chaisaingmongkol J; Ruchirawat M; Ruppin E; Greten TF; Wang XW
    Nat Commun; 2021 Mar; 12(1):1455. PubMed ID: 33674593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma.
    Liu T; Shi Q; Yang L; Wang S; Song H; Wang Z; Xu X; Liu H; Zheng H; Shen Z
    BMC Cancer; 2021 Aug; 21(1):957. PubMed ID: 34445994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma.
    Liu H; Jia S; Guo K; Li R
    Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35771229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.
    Zhang J; Song Q; Liu J; Lu L; Xu Y; Zheng W
    Dis Markers; 2019; 2019():8964015. PubMed ID: 31781310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification.
    Ouyang G; Li Q; Wei Y; Dai W; Deng H; Liu Y; Li J; Li M; Luo S; Li S; Liang Y; Pan G; Yang J; Gan T
    Front Immunol; 2024; 15():1323199. PubMed ID: 38742112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
    Wu M; Jiang L
    Dig Dis Sci; 2022 Jan; 67(1):146-158. PubMed ID: 33495920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of EPHX2 as a prognostic biomarker in hepatocellular carcinoma.
    Zhan K; Bai Y; Liao S; Chen H; Kuang L; Luo Q; Lv L; Qiu L; Mei Z
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome Profiling Identifies TIGIT as a Marker of T-Cell Exhaustion in Liver Cancer.
    Ostroumov D; Duong S; Wingerath J; Woller N; Manns MP; Timrott K; Kleine M; Ramackers W; Roessler S; Nahnsen S; Czemmel S; Dittrich-Breiholz O; Eggert T; Kühnel F; Wirth TC
    Hepatology; 2021 Apr; 73(4):1399-1418. PubMed ID: 32716559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-Dependent Kinase 4 is expected to be a therapeutic target for hepatocellular carcinoma metastasis using integrated bioinformatic analysis.
    Zhang JN; Wei F; Lei LH; Yang Y; Yang Y; Zhou WP
    Bioengineered; 2021 Dec; 12(2):11728-11739. PubMed ID: 34784846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
    Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
    Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygous deletions of the CDKN2 gene and loss of heterozygosity of 9p in primary hepatocellular carcinoma.
    Piao Z; Park C; Lee JS; Yang CH; Choi KY; Kim H
    Cancer Lett; 1998 Jan; 122(1-2):201-7. PubMed ID: 9464511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD1
    Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X
    J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth.
    Wang Y; Gao B; Tan PY; Handoko YA; Sekar K; Deivasigamani A; Seshachalam VP; OuYang HY; Shi M; Xie C; Goh BKP; Ooi LL; Man Hui K
    FASEB J; 2019 Aug; 33(8):8759-8770. PubMed ID: 31022357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
    Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
    Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global microarray profiling identified
    Weng Q; Chen M; Li M; Zheng YF; Shao G; Fan W; Xu XM; Ji J
    J Med Genet; 2019 Jan; 56(1):32-38. PubMed ID: 30120213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.